文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

医院和ICU治疗的脓毒症发病率与死亡率:更新和扩展的系统评价和Meta分析结果

Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.
PubMed 文献 · Intensive Care Med · 2020-06-22
一句话结论汇总分析显示医院治疗脓毒症发病率为189/10万人年,病死率26.7%;ICU治疗脓毒症发病率为58/10万人年,病死率41.9%。

该研究更新并扩展了系统评价和Meta分析,检索13个电子数据库,纳入28项符合标准的研究,其中21项新研究数据与原始Meta分析的30项研究合并。合并后医院治疗脓毒症发病率为189/10万人年(95%CI 133-267),病死率26.7%(95%CI 22.9-30.7);ICU治疗脓毒症发病率为58/10万人年(95%CI 42-81),出院前病死率41.9%(95%CI 36.2-47.7)。2008年后医院治疗脓毒症发病率较总体时间框架升高46%。与IHME研究相比,本研究发现医院治疗脓毒症发病率约低50%。

要点

  • 医院治疗脓毒症合并发病率为189/10万人年(95%CI 133-267),合并病死率26.7%(95%CI 22.9-30.7)。
  • ICU治疗脓毒症合并发病率为58/10万人年(95%CI 42-81),出院前病死率41.9%(95%CI 36.2-47.7)。
  • 2008年后医院治疗脓毒症发病率较总体时间框架升高46%。
  • 与IHME研究相比,本研究发现医院治疗脓毒症发病率约低50%。
  • 多数纳入研究基于行政数据,限制了对时间趋势和地区差异的评估;大多数LMIC的脓毒症发病率仍未知。

适用人群与场景

  • 住院成人脓毒症患者,定义依据临床标准(Sepsis-1、-2:严重脓毒症标准,或Sepsis-3:脓毒症标准)或相关ICD编码。
  • 研究覆盖医院治疗和ICU治疗的脓毒症人群,包括高收入国家和低/中等收入国家(LMIC)的研究。

诊断标准与关键阈值

  • 脓毒症定义依据临床标准:Sepsis-1、-2采用严重脓毒症标准,Sepsis-3采用脓毒症标准,或使用相关ICD编码。

研究设计与关键结果

  • 研究类型为更新和扩展的系统评价和Meta分析,检索13个电子数据库,最终纳入28项符合标准的研究,其中21项新研究数据与原始Meta分析的30项研究合并进行随机效应Meta分析。
  • 医院治疗脓毒症合并发病率为189/10万人年(95%CI 133-267),合并病死率为26.7%(95%CI 22.9-30.7)。
  • ICU治疗脓毒症合并发病率为58/10万人年(95%CI 42-81),出院前病死率为41.9%(95%CI 36.2-47.7)。
  • 2008年后医院治疗脓毒症发病率较总体时间框架升高46%。
  • 与IHME研究相比,本研究发现医院治疗脓毒症发病率约低50%。

证据类型、等级与局限

  • 证据类型为系统评价和Meta分析。
  • 局限:多数纳入研究基于行政数据,限制了对时间趋势和地区差异的评估。
  • 局限:大多数LMIC的脓毒症发病率仍未知。

对床旁实践的改变

  • 本研究提供的脓毒症发病率和病死率数据可用于了解全球脓毒症负担,并与IHME估计进行比较。
  • 作者认为需要改进脓毒症流行病学监测,尤其是在LMIC。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To investigate the global burden of sepsis in hospitalized adults by updating and expanding a systematic review and meta-analysis and to compare findings with recent Institute for Health Metrics and Evaluation (IHME) sepsis estimates.

METHODS: Thirteen electronic databases were searched for studies on population-level sepsis incidence defined according to clinical criteria (Sepsis-1, -2: severe sepsis criteria, or sepsis-3: sepsis criteria) or relevant ICD-codes. The search of the original systematic review was updated for studies published 05/2015-02/2019 and complemented by a search targeting low- or middle-income-country (LMIC) studies published 01/1979-02/2019. We performed a random-effects meta-analysis with incidence of hospital- and ICU-treated sepsis and proportion of deaths among these sepsis cases as outcomes.

RESULTS: Of 4746 results, 28 met the inclusion criteria. 21 studies contributed data for the meta-analysis and were pooled with 30 studies from the original meta-analysis. Pooled incidence was 189 [95% CI 133, 267] hospital-treated sepsis cases per 100,000 person-years. An estimated 26.7% [22.9, 30.7] of sepsis patients died. Estimated incidence of ICU-treated sepsis was 58 [42, 81] per 100,000 person-years, of which 41.9% [95% CI 36.2, 47.7] died prior to hospital discharge. There was a considerably higher incidence of hospital-treated sepsis observed after 2008 (+ 46% compared to the overall time frame).

CONCLUSIONS: Compared to results from the IHME study, we found an approximately 50% lower incidence of hospital-treated sepsis. The majority of studies included were based on administrative data, thus limiting our ability to assess temporal trends and regional differences. The incidence of sepsis remains unknown for the vast majority of LMICs, highlighting the urgent need for improved epidemiological sepsis surveillance.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020. PMID: 32572531. doi:10.1007/s00134-020-06151-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。